BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,039,495 | +2.9% | 289,701 | +21.9% | 0.01% | 0.0% |
| Q1 2023 | $1,981,709 | -8.2% | 237,615 | +26.4% | 0.01% | -12.5% |
| Q4 2022 | $2,158,229 | +3.6% | 187,999 | +13.7% | 0.01% | 0.0% |
| Q3 2022 | $2,083,000 | -21.1% | 165,341 | -33.8% | 0.01% | -20.0% |
| Q2 2022 | $2,641,000 | +14.1% | 249,639 | +75.3% | 0.01% | +42.9% |
| Q1 2022 | $2,315,000 | -29.2% | 142,377 | -39.7% | 0.01% | -22.2% |
| Q4 2021 | $3,272,000 | +23.1% | 236,217 | +27.8% | 0.01% | +12.5% |
| Q3 2021 | $2,657,000 | -2.8% | 184,890 | +6.9% | 0.01% | -11.1% |
| Q2 2021 | $2,734,000 | +168.8% | 172,901 | +72.9% | 0.01% | +125.0% |
| Q1 2021 | $1,017,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |